"Carcinoma in Situ" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Descriptor ID |
D002278
|
| MeSH Number(s) |
C04.557.470.200.240
|
| Concept/Terms |
Carcinoma in Situ- Carcinoma in Situ
- Carcinoma, Preinvasive
- Preinvasive Carcinoma
- Carcinoma, Intraepithelial
- Intraepithelial Carcinoma
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma in Situ".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma in Situ".
This graph shows the total number of publications written about "Carcinoma in Situ" by people in this website by year, and whether "Carcinoma in Situ" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 5 | 4 | 9 |
| 2003 | 2 | 2 | 4 |
| 2004 | 0 | 2 | 2 |
| 2005 | 2 | 2 | 4 |
| 2006 | 1 | 1 | 2 |
| 2007 | 3 | 1 | 4 |
| 2008 | 4 | 0 | 4 |
| 2009 | 1 | 0 | 1 |
| 2010 | 3 | 1 | 4 |
| 2011 | 4 | 1 | 5 |
| 2012 | 5 | 0 | 5 |
| 2013 | 3 | 1 | 4 |
| 2014 | 1 | 1 | 2 |
| 2015 | 2 | 1 | 3 |
| 2016 | 4 | 0 | 4 |
| 2020 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma in Situ" by people in Profiles.
-
Hong MJ, Lum SS, Dupont E, Howard-McNatt M, Chiba A, Levine EA, Gass JS, Gallagher K, Fenton A, Murray M, Solomon NL, Ollila DW, Lazar M, Namm JP, Walters LL, Chagpar AB. Omission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care. J Surg Res. 2022 11; 279:393-397.
-
Shields CL, Kim M, Lally SE, Ch?vez-Barrios P, Shields JA. Eye cancer in a young male with a vaping history. Indian J Ophthalmol. 2020 Aug; 68(8):1699-1701.
-
Parsel SM, Iarocci AL, Gastañaduy M, Winters RD, Marino JP, McCoul ED. Reflux Disease and Laryngeal Neoplasia in Nonsmokers and Nondrinkers. Otolaryngol Head Neck Surg. 2020 Sep; 163(3):560-562.
-
Machan M, Brodland D, Zitelli J. Penile Squamous Cell Carcinoma: Penis-Preserving Treatment With Mohs Micrographic Surgery. Dermatol Surg. 2016 Aug; 42(8):936-44.
-
Valent?n-Nogueras SM, Brodland DG, Zitelli JA, Gonz?lez-Sep?lveda L, Nazario CM. Mohs Micrographic Surgery Using MART-1 Immunostain in the Treatment of Invasive Melanoma and Melanoma In Situ. Dermatol Surg. 2016 Jun; 42(6):733-44.
-
Scott RB, Dolkar T, Vidhun R, Osler T, Staradub VL. Does Initial Imaging Modality Affect Breast Biopsy Upgrade Rates? A Single Institution Review. Conn Med. 2016 Jun-Jul; 80(6):335-40.
-
Coman RM, Schlachterman A, Esnakula AK, Draganov PV, Yang D. EUS-guided, through-the-needle forceps: clenching down the diagnosis. Gastrointest Endosc. 2016 Aug; 84(2):372-3.
-
Shields CL, Shields JA. Ocular Surface Squamous Neoplasia: From Blue Skies to Blue Dyes--We Still Need Our Ophthalmic Pathologists. JAMA Ophthalmol. 2015 Nov; 133(11):1321-2.
-
Kunishige JH, Brodland DG, Zitelli JA. Surgical margins for melanoma in situ: when 5-mm margins are really 9 mm. J Am Acad Dermatol. 2015 Apr; 72(4):745.
-
Pietzak EJ, Sterling ME, Smith ZL, Malkowicz SB, Guzzo TJ. Outcomes of radical cystectomy in potential candidates for bladder preservation therapy. Urology. 2015 Apr; 85(4):869-75.